Dana-Farber Cancer Institute, Yawkey 306
450 Brookline Ave, Boston
Engineers from MIT and the Koch Institute will present new
technologies for cancer diagnosis and drug development. The aim of the session is to stimulate new collaborations between MIT and the Koch Institute scientists and engineers with DF/HCC members. We have issued a new RFA this spring for the next round of Bridge funding, with applications due on September 5, 2013. Each team can request up to $750,000 over two years. Applications will be accepted from teams addressing unmet clinical needs in eight areas: Lung, pancreas, GBM, ovarian, melanoma, metastatic prostate cancer, metastatic breast cancer and adult leukemia.